NPR interviewed Dr. Reisa Sperling about the upcoming A4 trial and why it is unprecedented in the field of Alzheimer’s clinical research.
One of the longest and most anticipated Alzheimer drug studies in history is about to begin, and Dr. Reisa Sperling is wondering if people will come. It’s called the A4 study, and Sperling is the project leader.